Erälinna, J-P. Rokotukset ja neurologinen sairaus: Guillain-Barrén oireyhtymä, MS-tauti ja ADEM. Duodecim 2010;126:803–9.
MS-sjukdom
Kinnunen, E. Multippeliskleroosi-potilaan saa rokottaa. Duodecim 2001;117:2001–2002.
Farez, MF, Correale, J. Yellow fever vaccination and increased relapse rate in travelers with multiple sclerosis. Arch Neurol. 2011;68:1267–71.
Loebermann, M ym. Vaccination against infection in patients with multiple sclerosis. Nat Rev Neurol. 2012;8:143–151.
Agmon-Levin, N ym. Transverse myelitis and vaccines: a multi-analysis. Lupus 2009;18:1198–204.
Ahlgren, C ym. A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk. Eur J Epidemiol. 2009(a);24:541–52.
Ahlgren, C ym. Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations. Acta Neurol Scand 2009(b);119:313–20.
Guillain-Barrés syndrom (GBS)
Prevention and Control of Influenza with Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR 2010; 59:1–62.
Baxter, R ym. Recurrent Guillain-Barre syndrome following vaccination. Clin Infect Dis. 2012 Mar;54:800–4.
Stowe, J ym. Investigation of the temporal association of Guillain - Barré syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. Am J Epidemiol 2009;169:382–8.
Pritchard, J ym. Risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation. J Neurol Neurosurg Psychiatry 2002;73:348–9.
Hughes, RA ym. Immunization and risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1996;19:1230–1.
Kuitwaard, K ym. Initial symptoms, intercurrent events and long-term disability in GBS and CIDP. J Periph Nerv Syst 2009;14 Suppl:81–2.
Myastenia gravis
Zinman, L ym. Safety of influenza vaccination in patients with myasthenia gravis: a population-based study. Muscle Nerve 2009;40:947–51.